©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Inhibition of Lipopolysaccharide Biosynthesis and Cell Growth following Inactivation of the kdtA Gene in Escherichia coli(*)

(Received for publication, July 18, 1995; and in revised form, September 11, 1995)

Charles J. Belunis (1)(§) Tony Clementz (2) Sherry M. Carty (2)(¶) Christian R. H. Raetz (1) (2)(**)

From the  (1)Department of Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065 and the (2)Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The enzyme 3-deoxy-D-manno-octulosonic acid (Kdo) transferase is encoded by the kdtA gene in Escherichia coli. The enzyme is a single polypeptide that catalyzes the transfer of two Kdo residues to a tetraacyldisaccharide-1,4`-bisphosphate precursor of lipid A, designated lipid IV(A) (Belunis, C. J., and Raetz, C. R. H.(1992) J. Biol. Chem. 267, 9988-9997). To determine if Kdo transfer to lipid IV(A) is required for growth, we constructed a strain of E. coli with a chromosomal kdtA::kan insertion mutation. In mutants carrying the kdtA::kan allele on the chromosome, cell growth and Kdo transferase activity were dependent upon a copy of the intact kdtA gene on a plasmid. When the kdtA-bearing plasmid was itself temperature sensitive for replication, the growth of these strains was inhibited after several hours at 44 °C, and Kdo transferase activity in extracts became undetectable. Concomitantly, the cells accumulated massive amounts of lipid IV(A), the precursor of (Kdo)(2)-lipid IV(A). The kdtA::kan mutation could also be complemented by hybrid plasmids bearing the gseA gene of Chlamydia trachomatis. gseA specifies a distinct Kdo transferase that adds three Kdo moieties to lipid IV(A). Lipopolysaccharide from E. coli kdtA::kan constructs complemented by gseA reacts strongly with antibodies directed against the genus-specific epitope of Chlamydia, whereas lipopolysaccharide from parental E. coli K-12 does not. Our studies prove that Kdo attachment during lipid A biosynthesis is essential for cell growth and accounts for the conditional lethality associated with mutations in Kdo biosynthesis.


INTRODUCTION

The sugar 3-deoxy-D-manno-octulosonic acid (Kdo) (^1)appears to be an essential component of the lipopolysaccharide (LPS) of Escherichia coli and other Gram-negative bacteria(1, 2, 3, 4, 5, 6) . The enzyme Kdo transferase catalyzes the sequential addition of two Kdo sugars onto a molecule of lipid IV(A)(7, 8) , a key precursor of lipid A (Fig. 1). Prior to its incorporation, Kdo is activated to CMP-Kdo by the enzyme CMP-Kdo synthase(9, 10, 11) . Mutants of Salmonella typhimurium defective in Kdo biosynthesis are temperature sensitive for growth and accumulate several underacylated precursors of lipid A(12, 13, 14) , the most abundant of which is lipid IV(A)(15, 16) . Pharmacological inhibition of CMP-Kdo synthase in living cells has similar effects on LPS biogenesis (17, 18, 19, 20) .


Figure 1: Kdo transfer and the completion of lipid A assembly in E. coli. The six enzymatic reactions leading to the formation of lipid IV(A) have been reviewed elsewhere(2) . The chromosomal kdtA gene of E. coli is a bifunctional enzyme catalyzing both the first and the second Kdo transfers, as indicated(8, 21) . The Kdo transferase encoded by the gseA gene of C. trachomatis (not shown) catalyzes an additional, third Kdo transfer to the 8 position of the outer Kdo sugar(33) .



Recently, Clementz and Raetz (21) described a colony screening technique to identify E. coli mutants with thermolabile Kdo transferase in cell extracts. Using these mutants, they were able to isolate the Kdo transferase gene, designated as kdtA(21) . Although cell extracts of these mutants contain <5% of wild-type Kdo transferase activity, when assayed at 42 °C, the strains do not display temperature-sensitive growth, and they do not accumulate lipid IV(A) at 42 °C(21) . It appears that these mutants retain enough residual Kdo transferase activity in vivo to synthesize adequate levels of (Kdo)(2)-lipid IV(A).

Kdo is a component of capsular polysaccharides in some strains of E. coli and related bacteria(6, 22, 23) . Since Kdo-containing polymers other than LPS are not found in all Gram-negative bacteria(6, 22, 23) , it seems unlikely that the presence of Kdo in these polymers would account for the conditional lethality of the Kdo biosynthesis mutants. Nevertheless, the question of whether or not Kdo transfer to lipid IV(A)per se is essential for cell growth could only be tested by examining the consequences of complete inactivation of the kdtA gene.

In this paper, we demonstrate that the kdtA gene is indeed essential for growth of E. coli by constructing a kdtA::kan insertion mutation, using a gene replacement method(24) . Growth of this strain is absolutely dependent upon the presence of a functional copy of the kdtA gene (or the related gseA gene) carried on a plasmid.


EXPERIMENTAL PROCEDURES

Materials

[-P]ATP, [alpha-P]dCTP, and P(i) were obtained from Amersham International. CTP and Kdo were obtained from Sigma. Restriction enzymes and T4 DNA ligase were purchased from Boehringer Mannheim. Other items were purchased from the following companies: yeast extract and tryptone (Difco Laboratories, Detroit, MI); Silica Gel 60 thin layer plates, 0.25 mm (E. Merck, Darmstadt, Germany); PRIME IT random primer kit (Stratagene); and Hybond nylon membranes (Amersham Corp.). The primary mouse monoclonal antibody CT403.1 (1 mg/ml), directed against the genus-specific epitope of Chlamydia trachomatis, was from Dr. Wayne Beyer (Becton-Dickinson, Research Triangle Park, NC). The secondary antibody (horseradish peroxidase-conjugated goat anti-mouse) was from Promega. Lipid IV(A) and 4`-P lipid IV(A) were prepared as described(7, 15) . CMP-Kdo synthase was partially purified from E. coli(7) .

Plasmids, Bacterial Strains, and Growth Conditions

All plasmids and bacterial strains employed in this study are listed in Table 1. The medium for growth of cells in liquid culture or on agar plates was Luria broth (LB), consisting of 5 g of yeast extract, 10 g of tryptone, and 10 g of NaCl per liter(25) . Media were supplemented with ampicillin (125 µg/ml), tetracycline (25 µg/ml), chloramphenicol (10 µg/ml), or kanamycin (20 µg/ml) as indicated to select for cells resistant to these drugs. Sensitivity or resistance to UV light was determined by survival after irradiation with 254 nm UV light as described by Ausubel et al.(26) .



DNA Techniques

E. coli chromosomal DNA was isolated as described by Ausubel et al.(26) . Large-scale preparation of plasmid DNA was carried out by the method of Birnboim and Doly(27) . Specific DNA probes were labeled with [alpha-P]dCTP using the PRIME IT random primer kit (Stratagene) according to manufacturer's specifications. Southern blot hybridizations (28) were performed as described by Maniatis et al.(29) . Restriction endonucleases and T4 DNA ligase were used according to the manufacturer's specifications. DNA fragments were isolated from agarose gels using Geneclean (Bio-Sci 101). All other techniques were adapted from Ausubel et al. (26) .

Transformation of E. coli Cells

E. coli cells were made competent for transformation by CaCl(2) treatment as described previously(30) . Transformants were plated on LB containing the required antibiotic and incubated at 30 or 37 °C as indicated.

Kdo Transferase Assay

Kdo transferase activity was assayed as described previously by Brozek et al.(7) . Reaction mixtures contained 50 mM Hepes, pH 7.0, 10 mM MgCl(2), 3.2 mM Triton X-100, 5 mM CTP, 2 mM Kdo, 100 µM 4`-P lipid IV(A) (3-6 times 10^3 cpm/nmol), 1.8 milliunits of CMP-Kdo synthase, and enzyme protein in a total volume of 20 µl. Assays were carried out for 10-20 min at 30 °C in 0.6-ml Eppendorf tubes. Reactions were terminated by spotting 5 µl of the assay mixtures onto silica thin layer plates. The plates were air dried and then developed in chloroform/pyridine/88% formic acid/water (30:70:16:10 (v/v)). Alternatively [1-^14C]Kdo (3200 cpm/nmol) was used as the labeled substrate(21) . The P- or ^14C-labeled products were located by autoradiography, scraped into scintillation vials, and counted in 10 ml of Biosafe mixture (Research Products Intl., Mount Prospect, IL). In some experiments, the labeled product was detected with an automatic TLC-linear analyzer (Berthold Analytical Instruments, Nashua, NH). A unit of enzymatic activity is defined as the amount of enzyme required to catalyze the formation of 1 nmol of product per min. Specific activity is defined as units per mg of protein(8) .

Plasmid Construction

To construct pJSC20 (Fig. 2), pMAK705 (24) and pCL3 (21) were digested with BamHI and HindIII. The 3-kb fragment from pCL3, containing kdtA, was purified by gel electrophoresis and ligated into pMAK705. The ligation mixture was used to transform competent cells of JM109(31) . Plasmid-bearing cells were selected by growth on LB plates containing chloramphenicol at 30 °C. Surviving colonies were tested for the presence of the desired insert, and extracts were assayed for elevated levels of Kdo transferase activity. pJSC2 contained the predicted insert with its characteristic, single SalI restriction site located within the kdtA gene(21) .


Figure 2: pJSC20 contains a kdtA gene disrupted by a kan insertion. The construction of pJSC20 is described in detail under ``Experimental Procedures.'' The selections for plasmids pJSC2 and pJSC20 were based on chloramphenicol resistance or chloramphenicol and kanamycin resistance, respectively. The chloramphenicol resistance gene and the temperature-sensitive replicon are indicated as cam and rep, respectively.



pJSC2 and pUC-4K were digested with SalI. The kanamycin cassette from pUC-4K was purified by gel electrophoresis and ligated into pJSC2. The ligation mixture was used to transform competent cells of JM109. Plasmid-bearing cells were selected by growth at 30 °C on LB plates containing chloramphenicol and kanamycin. pJSC20 showed the expected restriction sites, and extracts did not express elevated levels of Kdo transferase activity, indicating disruption of the plasmid-born kdtA gene. Cells carrying pJSC20 grew well in the presence of chloramphenicol and kanamycin at 30 °C but not at 44 °C, confirming that the plasmid pJSC20 is temperature sensitive for replication.

Construction of a Mutant with an Insertion in the Chromosomal Copy of kdtA

The construction of CJB26 (Table 1) was carried out using the methods of Hamilton et al.(24) . Competent cells of MC1061 (32) were transformed with pJSC20. Following growth to mid-log phase at 30 °C, cells were plated on prewarmed LB plates, containing chloramphenicol and kanamycin, and incubated at 44 °C. Cells in which the plasmid had integrated into the chromosome were selected by growth at 44 °C. A single colony of such a cointegrate was used to inoculate 1 ml of LB broth, containing chloramphenicol, and was incubated at 30 °C for 6 h. Next, the culture was used to inoculate 100 ml of LB broth, containing chloramphenicol, and was grown to stationary phase at 30 °C. A portion of the culture was then diluted 1:100,000, and the cells were grown to stationary phase. This process was repeated a second time, given that at 30 °C the cointegrates are unstable and can excise (Fig. 3) to generate a free plasmid, carrying either the wild-type kdtA gene or the kdtA::kan allele(24) . Following the above cycles of outgrowth, the cells were plated on LB medium containing chloramphenicol at 30 °C. Plasmid-containing cells were identified by their inability to grow to 44 °C on chloramphenicol plates. Rapid plasmid screens were performed on 15 of such temperature-sensitive strains. Plasmids isolated from 6 of these strains were the same size as pJSC20. The other 9 strains contained smaller plasmids, indicating that the kdtA::kan insertion of pJSC20 had replaced the wild-type kdtA gene on the chromosome (Fig. 3). One of these isolates (designated CJB26) was made recA by P1 transduction using JC10241 (32) as the donor. The presence of the recA phenotype in CJB26 was confirmed by its sensitivity to UV light.


Figure 3: Construction of an E. coli strain bearing a chromosomal kdtA gene disrupted by a kan insertion. The construction of CJB26 (Table 1), which is based on homologous recombination at 44 °C followed by resolution of the cointegrate at 30 °C, is described in detail under ``Experimental Procedures.'' Pathway B, leading to CJB26, leaves the inactivated kdtA gene behind on the chromosome. The covering plasmid of CJB26 is identical to pJSC2, as drawn in Fig. 2. The chloramphenicol resistance gene and the temperature-sensitive replicon are indicated as cam and rep, respectively.



Strain NEB1 was constructed by transforming competent cells of CJB26 with pKEM1, which contains the C. trachomatis gseA gene(33) . The kdtA-bearing plasmid of CJB26 was cured by growth at 44 °C in the absence of chloramphenicol but in the presence of ampicillin to select for pKEM1. The presence of pKEM1 as the only plasmid in the surviving colonies was confirmed by rapid plasmid isolation and restriction digestion analysis.

Phospholipid Analysis

Phospholipids were labeled, extracted, and analyzed as described(34, 35) . Steady-state phospholipid composition was determined by uniformly labeling cells in LB medium containing P(i) (20 µCi/ml). Fresh LB containing P(i) (20 µCi/ml) was used to dilute cultures when necessary. Radiolabeled phospholipids were extracted from cells by transferring 0.8 ml of the cultures to glass tubes containing 3 ml of chloroform/methanol (1:2 (v/v)). The contents of the tubes were mixed and allowed to stand at room temperature for 1 h. The tubes were centrifuged for 20 min at low speed to remove insoluble material. The supernatants were transferred to new glass tubes containing 10 µg of E. coli phospholipids. A two-phase system was made by the addition of 1 ml of chloroform and 1 ml of 0.2 M HCl. The contents of the tubes were mixed, and the resulting phases were separated by a brief centrifugation. The upper phases were removed, and each lower phase was concentrated by evaporation under a stream of nitrogen. A portion of the phospholipids (5 times 10^4 cpm) was spotted onto silica gel plates. The phospholipids were separated by thin layer chromatography in the solvent chloroform/pyridine/88% formic acid/water (40:60:16:5 (v/v)). The P-labeled phospholipids were located by autoradiography.


RESULTS

Temperature-sensitive Growth of Strain CJB26

E. coli strain CJB26 was derived by replacement of the chromosomal copy of kdtA with the kan element disrupted kdtA gene of pJSC20 by homologous recombination (Fig. 3, reaction B). The recA gene was subsequently introduced by P1 transduction, using JC10241 (32) as the donor. CJB26 is chloramphenicol and kanamycin resistant at 30 °C. The excised, recombinant plasmid in strain CJB26 (Fig. 3, reaction B) is identical to pJSC2 (Fig. 2) and is temperature sensitive for replication. Shifting the growth temperature from 30 to 44 °C inhibits replication of the plasmid DNA and the transfer of the intact kdtA gene (and chloramphenicol resistance) to daughter cells.

To determine whether or not the kdtA gene is essential for growth, cells of CJB26 from an overnight culture grown at 30 °C in the presence of chloramphenicol were inoculated into LB medium lacking chloramphenicol at A of 0.1 (Fig. 4). Cells were then cultured at 44 °C with intermittent back dilution to maintain the A between 0.06 and 0.6. The results are plotted as a cumulative growth yield at 44 °C (Fig. 4). After about 4 h, the plating efficiency of CJB26, as judged by growth of single colonies on LB agar lacking chloramphenicol at 30 °C (Fig. 4), stopped increasing. However, the A of CJB26 continued to rise slowly. The control strain, MC1061/pJSC2, continued to grow rapidly after the temperature shift, since the plasmid copies of the kdtA gene were not needed in MC1061 for growth in LB medium at 44 °C without chloramphenicol (Fig. 4). The results of Fig. 4demonstrate that the kdtA gene is essential.


Figure 4: Temperature-sensitive growth of CJB26. Overnight cultures of CJB26 and MC1061/pJSC2 were grown in LB broth supplemented with chloramphenicol at 30 °C. Cultures were diluted into LB broth without chloramphenicol to an absorbance at 600 nm of 0.1, and growth was continued at 44 °C. To maintain exponential growth, the cultures were diluted 10-fold into fresh prewarmed medium lacking chloramphenicol every time the A reached 0.6. Samples for the zero time points were taken just prior to the temperature shift. The A values for strains CJB26 and MC1061/pJSC2 were corrected for dilution of the culture and therefore represent a cumulative growth yield. Viability (also corrected for dilution) of strains CJB26 and MC1061/pJSC2 was determined by diluting and plating portions of the cultures onto LB plates without chloramphenicol at 30 °C. In a separate experiment (data not shown), the loss of plasmid DNA in MC1061/pJCS2 at 44 °C was confirmed by determining viable cell count on LB plates containing chloramphenicol at 30 °C. The number of chloramphenicol-resistant cells increased for 1-2 h following the temperature shift (data not shown), but the viable count of MC1061/pJSC2 on chloramphenicol then decreased by several orders of magnitude as a percentage of the total number of cells in the culture, indicating the loss of plasmid DNA. The viability of CJB26 on LB plates containing chloramphenicol at 30 °C (data not shown) was comparable to its viability in the absence of chloramphenicol, indicating that only cells possessing recombinant plasmid with a functional copy of kdtA could grow.



Loss of Kdo Transferase Activity at 44 °C

Kdo transferase activity was assayed in extracts of both MC1061/pJSC2 and CJB26 following a temperature shift from 30 to 44 °C (Fig. 5) in LB medium lacking chloramphenicol. The specific activity of Kdo transferase in extracts of MC1061/pJSC2 was 3-fold higher than wild type at the time of temperature shift but gradually declined to wild type levels after 2.5 h at 44 °C (Fig. 5). This behavior is consistent with the loss of pJSC2. The specific activity of Kdo transferase in extracts of CJB26 at the time of the temperature shift was approximately 2 nmol/min/mg lower than MC1061/pJSC2 (Fig. 5), consistent with the lack of the chromosomal copy of kdtA in CJB26. The specific activity in extracts of CJB26 decreased to wild-type levels after 2 h at 44 °C (Fig. 5) but continued to drop until no activity was detected in extracts from cells that had been held at 44 °C for 7 h. The time at which the Kdo transferase specific activity in extracts of CJB26 dropped to levels below wild type (Fig. 5) was about the same the time at which cell viability stopped increasing (Fig. 4).


Figure 5: Dilution of Kdo transferase specific activity in extracts of CJB26 and MC1061/pJSC2 grown at 44 °C. Cells were subjected to a temperature shift as in Fig. 4. At the indicated time points, portions of the cells were harvested by centrifugation, and the cells were broken by passage through a cold French pressure cell at 18,000 psi. Cell-free extracts were assayed for protein and Kdo transferase activity as described under ``Experimental Procedures.''



Effect of Plasmid Loss on Lipid IV Accumulation in CJB26

Temperature-sensitive S. typhimurium mutants defective in Kdo biosynthesis accumulate underacylated lipid A disaccharide precursors when grown at 42 °C(12, 13) . For instance, when the kdsA-deficient mutant STi50 is uniformly labeled with P(i) at 30 °C and then shifted to 42 °C, one observes massive accumulation of lipid A precursors, as judged by thin layer chromatography(15, 16) . The predominant precursor is lipid IV(A) (Fig. 1), which represents as much as 5-10% of the chloroform-soluble substances extracted from the bacteria under non-permissive conditions. In wild-type cells, lipid IV(A) represents less than 0.1% of the total chloroform-soluble polar lipids.

In the experiment of Fig. 6, cells of mutant STi50 and CJB26 were grown in parallel at 30 °C and were uniformly labeled with P(i). The STi50 culture was shifted to 44 °C when the A had reached 0.8. A portion was harvested just before and 2 h after the temperature shift for analysis of lipid composition. The CJB26 culture was first diluted to an A of 0.1 with excess medium containing P(i), and then it was shifted to 44 °C. The CJB26 culture was given time to lose its covering plasmid and Kdo transferase activity by intermittent 10-fold back dilution in media containing P(i) whenever the A had reached 0.6. Over the course of 9.5 h, portions of the CJB26 culture were removed, and the phospholipids were extracted under acidic Bligh-Dyer conditions(34) . Samples of 5 times 10^4 cpm of uniformly labeled phospholipids obtained at each time point were spotted onto a silica gel plate, which was developed in chloroform/pyridine/88% formic acid/water (40:60:16:5 (v/v)). The plate was analyzed by autoradiography (Fig. 6). Cells of the kdsA-deficient mutant STi50 accumulated large amounts of lipid IV(A) after 2 h at 44 °C (Fig. 6). Prior to the temperature shift, the lipids of CJB26 consisted mainly of glycerophospholipids, which migrated rapidly in the solvent system employed. After 6.5 h at 44 °C, CJB26 also accumulated lipid IV(A) (Fig. 6). The timing of lipid IV(A) accumulation approximately coincided with the complete loss of measurable Kdo transferase activity (compare Fig. 4and Fig. 6). Wild-type E. coli do not accumulate lipid IV(A) at any growth temperature.


Figure 6: Lipid IV(A) accumulation in CJB26 grown at 44 °C and in a temperature-sensitive mutant of S. typhimurium defective in Kdo biosynthesis. Cells of the S. typhimurium mutant STi50 and the E. coli strain CJB26 were grown for three generations at 30 °C on LB broth containing P(i) (20 µCi/ml). When the absorbance at 600 nm had reached 0.8, the STi50 cells were shifted to 44 °C, and the CJB26 culture was diluted to an A of 0.1 prior to the temperature shift. To maintain exponential growth, the CJB26 culture was diluted 1:10 whenever the A reached 0.6. At the time of the temperature shift (designated 0) and at the indicated times, samples were withdrawn, and the lipids were extracted under acidic conditions(34) . A portion of the radioactive lipids was spotted onto a silica gel plate that was developed in chloroform/pyridine/88% formic acid/water (40:60:16:5 (v/v)). The glycerophospholipids migrated rapidly, whereas lipid IV(A) migrated more slowly. The accumulation of lipid IV(A) is detectable in STi50 after 2 h at 44 °C, and in CJB26, after 6 h at 44 °C. Lipid IV(A) is not detectable in STi50 at 30 °C or CJB26 at 30 °C. Wild-type E. coli cells also do not accumulate lipid IV(A) at 30 °C or during prolonged incubations at 44 °C (data not shown).



Rescue of the kdtA::kan Mutation of CJB26 by the C. trachomatis gseA Gene

Strain NEB1 (Table 1) was constructed by transforming CJB26 with pKEM1, followed by selection for growth at 44 °C to dilute out pJSC2. NEB1 was sensitive to UV light, but it was ampicillin and kanamycin resistant at both 44 and 30 °C. NEB1 grew more slowly than did MC1061 (Fig. 7), especially at 42 °C in shaking culture. NEB1 was nevertheless able to form colonies on LB agar at 42-44 °C.


Figure 7: Growth of MC1061 and NEB1 at various temperatures. Overnight cultures of MC1061 and NEB1 were grown at 30 °C in LB broth. Cultures of NEB1 were also supplemented with ampicillin at 125 µg/ml. Following dilution into fresh medium, cells were grown at 30 °C until A was 0.2. Portions of these cultures were then grown at 30, 37, or 42 °C, starting at time 0 as indicated. Intermittent back dilution was carried out as required to maintain the A between 0.06 and 0.6. The A shown on the y axis therefore represents a cumulative growth yield.



Southern blots of chromosomal DNA isolated from MC1061 and NEB1 were prepared and probed with a P-labeled 1.7-kb EcoRV fragment containing the complete kdtA gene. Restriction digestion of the chromosomal DNA with EcoRV should produce fragments of 1.7 kb from cells containing the wild-type kdtA gene (MC1061) and 3 kb from cells containing the kan insertion within the kdtA gene (NEB1). Digestion of DNA isolated from NEB1 with ClaI should produce fragments of approximately 1.8 and 1.2 kb because of a single ClaI site inside the kan gene. The predicted fragments were indeed observed (Fig. 8). These results confirmed that the kan cassette was located within the kdtA gene of NEB1 and, by inference, of CJB26.


Figure 8: Southern blot of chromosomal DNA from NEB1 and MC1061. Genomic DNA was isolated from E. coli strains NEB1 and MC1061, and it was subjected to restriction enzyme digestion with either EcoRV (E) or ClaI (C). The resulting fragments were separated by agarose gel electrophoresis. Following transfer of the DNA to a nylon membrane, the blot was probed with a P-labeled, 1.7-kb EcoRV fragment containing the complete kdtA gene. The positions of standards of defined molecular weight are indicated.



Extracts of the kdtA point mutant TC5 (21) contain <5% of wild-type Kdo transferase activity when assayed at 42 °C. Extracts of TC5 cells transformed with the gseA-bearing plasmid pKEM1 regain Kdo transferase activity at 42 °C, generating not only (Kdo)(2)-lipid IV(A) but also (Kdo)(3)-lipid IV(A)(33) . Extracts of NEB1 were similarly capable of transferring three Kdos onto lipid IV(A) (Fig. 9, panel A) in the absence of any residual KdtA activity. The steady state level of (Kdo)(1)-lipid IV(A) (Fig. 9, panel A) is somewhat higher in the reaction catalyzed by the gseA gene product than by the kdtA-encoded enzyme (Fig. 9, panel B). This observation suggests that the two Kdo transferases differ not only with respect to their ability to incorporate the third Kdo residue but also in the relative rates at which they catalyze the first and second glycosylations.


Figure 9: Kdo transferase activity in extracts of NEB1 and MC1061. The assay contains 50 mM Hepes, pH 7.5, 3.2 mM Triton X-100, 2 mM Kdo, 100 µM 4`-P lipid IV(A) (1.2 times 10^3 cpm/nmol), 5 mM CTP, 2 milliunits of CMP-Kdo synthase, 10 mM MgCl(2), and 1.0 mg/ml cell extract. The reactions were incubated for the indicated times. Panel A, E. coli NEB1. Panel B, E. coli MC1061.



Specific Binding of an Antibody Directed Against the Genus-specific Epitope by NEB1

As shown in the dot blots of Fig. 10, unfractionated cell extracts of NEB1 react strongly with a mouse monoclonal antibody (CT403.1) directed against the genus-specific epitope of C. trachomatis, whereas comparable preparations of MC1061 do not. Even at 10-fold higher levels of primary antibody or cell extracts (not shown), no genus-specific epitope is detected in MC1061.


Figure 10: Dot blot analysis of extracts of NEB1 and MC1061 using a monoclonal antibody directed against the genus-specific epitope of C. trachomatis. Cells of MC1061 and NEB1 were grown to late log phase in LB broth. A portion of each culture (1 ml) was centrifuged to recover the cells. The pellets were resuspended in 200 µl of Laemmli loading buffer (50 mM Tris-chloride, pH 6.8, 2% SDS, 0.1% bromphenol blue, 10% glycerol, and 700 mM 2-mercaptoethanol), and the lysed samples were diluted with phosphate-buffered saline to final protein concentrations of 3-15 µg/ml. Next, 1-µl portions containing the amount of protein indicated were spotted onto a nitrocellulose membrane (0.45 micron Hybond-C super from Amersham) and allowed to dry for 5 min at 42 °C. The membrane was blocked for 1 h at room temperature in 30 ml of phosphate-buffered saline containing 6% Kroger nonfat dry milk and 0.02% sodium azide. The primary antibody (a 1 mg/ml stock of CT403.1) was exposed to the membrane at a 1:5000-fold dilution in a fresh 30-ml portion of the above blocking buffer. After 1 h, the membrane was rinsed three times with phosphate-buffered saline. Next, it was incubated for 1 h in another 30-ml portion of the above blocking buffer supplemented with secondary antibody at a 1:1000 dilution from a 1 mg/ml stock of Promega horseradish peroxidase-conjugated goat anti-mouse antibody. After several final washes with phosphate-buffered saline and distilled water, the genus-specific epitope was detected on the membrane by a 1-min incubation in 40 ml of enhanced chemiluminescence reagents (ECL Western blotting detection reagents from Amersham), followed by a 5-min exposure to Kodak X-OMAT x-ray film.



The phospholipid compositions of NEB1 and MC1061, grown in LB broth at 37 °C, were analyzed by P(i) labeling, as in Fig. 6. No accumulation of lipid IV(A) was observed in NEB1 (data not shown), demonstrating that GseA can function in vivo at a rate that is comparable to KdtA. The slow growth of NEB1 (Fig. 7) therefore cannot be attributed to inefficient Kdo transfer and lipid IV(A) accumulation.


DISCUSSION

Previous genetic and pharmacological studies have demonstrated that the biosynthesis and activation of Kdo are essential processes in Gram-negative bacteria(12, 13, 14, 15, 16, 17, 18, 19, 20) . When the formation of CMP-Kdo is blocked, cells accumulate large amounts of lipid IV(A), consistent with the pathway shown in Fig. 1(12, 13, 14, 15, 16, 17, 18, 19, 20) . However, given that Kdo can be a constituent of other cell surface molecules(6, 22, 23) , it is unclear whether the attachment of Kdo to lipid IV(A)per se is required for growth. An E. coli gene encoding a bifunctional Kdo transferase (kdtA) has previously been identified and sequenced(21) , but no conditional alleles or insertion mutations of kdtA have been reported. The physiological consequences of selective inhibition of Kdo transfer to lipid IV(A) therefore remained uncertain.

Using homologous recombination, we have now constructed an E. coli strain (CJB26) with a kan element insertion in the chromosomal copy of the kdtA gene (Fig. 3, pathway B). CJB26 retains a functional copy of kdtA on a hybrid plasmid (Fig. 3, pathway B) that is equivalent to pJSC2 (compare Fig. 2and Fig. 3). Since pJSC2 is derived from pMAK705 (24) and harbors a temperature-sensitive pSC101 replicon (Fig. 2), pJSC2 is capable of replicating at 30 °C but not at 44 °C. Cells of CJB26 are expected to survive only at the lower temperature if the kdtA gene is essential but would grow at both temperatures if the kdtA gene is not essential.

As shown by the behavior of CJB26 in the experiments of Fig. 4Fig. 5Fig. 6, the kdtA gene is indeed essential. Cells of CJB26 grown at 44 °C lose the ability to synthesize Kdo transferase as the plasmid is cured (Fig. 5). The decrease in Kdo transferase activity with time precedes the accumulation of lipid IV(A) in the cells (Fig. 6). As Kdo transferase activity falls below wild-type levels, growth slows and eventually ceases (Fig. 4). Only those daughter cells that retain the functional copy of kdtA on a plasmid can grow, while the other daughter cells cannot. Viable cell counts on LB plates both with and without chloramphenicol supplementation at 30 °C are identical in cultures of CJB26 shifted to 44 °C (data not shown). The absence of measurable Kdo transferase in extracts of CJB26 after 6 h at 44 °C (Fig. 5) indicates that there are no additional genes encoding for Kdo transferase isoenzymes in E. coli.

The decrease in the growth rate of CJB26 and the accumulation of lipid IV(A) during plasmid curing at 44 °C are similar to what occurs when temperature-sensitive Kdo biosynthesis mutants of S. typhimurium(12, 13, 14, 15, 16) are shifted to non-permissive conditions or when CMP-Kdo synthase inhibitors are added to wild-type Gram-negative bacteria(17, 18, 19, 20) . Our findings show that inhibition of LPS biosynthesis is sufficient to explain the antibacterial effects of CMP-Kdo synthase inhibitors and the conditional lethality of mutations in Kdo biosynthesis. It is still uncertain whether Kdo(2)-lipid IV(A) is actually required for growth or whether the accumulation of lipid IV(A) is toxic.

In previous studies(33) , we showed that the gseA gene of C. trachomatis codes for a novel Kdo transferase. The C. trachomatis Kdo transferase can add at least one additional Kdo onto Kdo(2)-lipid IV(A). Preliminary results also indicated that GseA might actually recognize lipid IV(A) as a substrate (33) , suggesting that GseA is a trifunctional Kdo transferase. The fact that we were able to replace the temperature-sensitive covering plasmid (pJSC2) present in CJB26 with a thermostable plasmid (pKEM1) bearing only gseA(33) provides strong support for the ability of GseA to use lipid IV(A) as a substrate in living cells. As expected from the ability of pKEM1 to rescue CJB26 at 44 °C, extracts of NEB1 were able to catalyze the formation of Kdo(1)-, Kdo(2)-, and Kdo(3)-lipid IV(A) from lipid IV(A) (Fig. 9), despite the insertional inactivation of the kdtA gene (Fig. 8). Why NEB1 cells grow more slowly than wild type, especially at elevated temperatures (Fig. 7), is uncertain, but it is not the result of lipid IV(A) accumulation.

Southern blot analysis (Fig. 8) confirmed the presence of the kan element within the chromosomal kdtA gene in NEB1. NEB1 was chosen as the source of the genomic DNA for Southern blotting, since the recombinant covering plasmid in NEB1 did not contain any kdtA sequences. A hybridizing band on a Southern blot could only be due to kdtA sequences present on the chromosome and not from contaminating plasmid DNA. Because of the latter issue, we did not use CJB26 grown at 44 °C as the source of genomic DNA.

In summary, we have constructed a strain of E. coli with an insertion mutation in the kdtA gene. Biosynthesis of Kdo(2)-lipid IV(A) and growth of the organism are absolutely dependent on the presence of a functional copy of an intact kdtA gene on a plasmid. The mutation can also be complemented by the gseA gene from C. trachomatis. The strain NEB1, which contains the kdtA::kan mutation on the chromosome and gseA on a plasmid, is viable, and it can synthesize Kdo-containing LPS that is recognized by an antibody directed against the genus-specific epitope (Fig. 10). It will be interesting to determine the precise structure of the LPS made by NEB1. Since NEB1 appears to make Kdo(3)-containing LPS (Fig. 10), the strain could prove to be a valuable source of the epitope for diagnostic assays and structural studies. NEB1 should also prove useful for the isolation of the trifunctional Kdo transferase, since no bifunctional Kdo transferase is present to complicate enzymatic assays.


FOOTNOTES

*
This research was supported in part by National Institutes of Health Grant GM-51310 (to C. R. H. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Present address: Dept. of Inflammation and Autoimmune Diseases, Hoffmann-La Roche, 340 Kingsland St., Nutley, NJ 07110.

Supported by a National Institutes of Health training grant in biological chemistry to Duke University.

**
Present address: Dept. of Biochemistry, Duke University Medical Center, Durham, NC 27710. To whom correspondence should be addressed.

(^1)
The abbreviations used are: Kdo, 3-deoxy-D-manno-octulosonic acid; LPS, lipopolysaccharide; kb, kilobase(s).


ACKNOWLEDGEMENTS

We thank Dr. Wayne Beyer of Becton-Dickinson (Research Triangle Park, NC) for providing monoclonal antibody CT403.1.


REFERENCES

  1. Raetz, C. R. H. (1990) Annu. Rev. Biochem. 59, 129-170 [CrossRef][Medline] [Order article via Infotrieve]
  2. Raetz, C. R. H. (1993) J. Bacteriol. 175, 5745-5753 [Medline] [Order article via Infotrieve]
  3. Rietschel, E. T., and Brade, H. (1992) Sci. Am. 267, 54-61 [Medline] [Order article via Infotrieve]
  4. Morrison, D. C., and Ryan, J. L. (eds) (1992) Bacterial Endotoxic Lipopolysaccharides , Vol. I, CRC Press, Boca Raton, FL
  5. Anderson, L., and Unger, F. M. (eds) (1983) Bacterial Lipopolysaccharides (ACS Symp. Series), Vol. 231, American Chemical Society, Wash. D. C.
  6. Unger, F. M. (1981) Adv. Carbohydr. Res. 38, 324-388
  7. Brozek, K. A., Hosaka, K., Robertson, A. D., and Raetz, C. R. H. (1989) J. Biol. Chem. 264, 6956-6966 [Abstract/Free Full Text]
  8. Belunis, C. J., and Raetz, C. R. H. (1992) J. Biol. Chem. 267, 9988-9997 [Abstract/Free Full Text]
  9. Ghalambor, M. A., and Heath, E. C. (1966) J. Biol. Chem. 241, 3216-3221 [Abstract/Free Full Text]
  10. Goldman, R. C., Bolling, T. J., Kohlbrenner, W. E., Kim, Y., and Fox, J. L. (1986) J. Biol. Chem. 261, 15831-15835 [Abstract/Free Full Text]
  11. Kohlbrenner, W. E., and Fesik, S. W. (1985) J. Biol. Chem. 260, 14695-14700 [Abstract/Free Full Text]
  12. Rick, P. D., and Osborn, M. J. (1977) J. Biol. Chem. 252, 4895-4903 [Medline] [Order article via Infotrieve]
  13. Rick, P. D., Fung, L. W.-M., Ho, C., and Osborn, M. J. (1977) J. Biol. Chem. 252, 4904-4912 [Abstract]
  14. Rick, P. D. (1987) in Escherichia coli and Salmonella typhimurium (Neidhardt, F., ed) Vol. 1, pp. 648-662, ASM Publications, Wash. D. C.
  15. Raetz, C. R. H., Purcell, S., Meyer, M. V., Qureshi, N., and Takayama, K. (1985) J. Biol. Chem. 260, 16080-16088 [Abstract/Free Full Text]
  16. Strain, S. M., Armitage, I. M., Anderson, L., Takayama, K., Quershi, N., and Raetz, C. R. H. (1985) J. Biol. Chem. 260, 16089-16098 [Abstract/Free Full Text]
  17. Goldman, R., Kohlbrenner, W., Lartey, P., and Pernet, A. (1987) Nature 329, 162-164 [Medline] [Order article via Infotrieve]
  18. Goldman, R. C., Doran, C. C., and Capobianco, J. O. (1988) J. Bacteriol. 170, 2185-2192 [Medline] [Order article via Infotrieve]
  19. Goldman, R. C., Doran, C. C., Kadam, S. K., and Capobianco, J. O. (1988) J. Biol. Chem. 263, 5217-5223 [Abstract/Free Full Text]
  20. Hammond, S. M., Claesson, A., Jansson, A. M., Larsson, L. G., Pring, B. G., Town, C. M., and Ekström, B. (1987) Nature 327, 730-732 [CrossRef][Medline] [Order article via Infotrieve]
  21. Clementz, T., and Raetz, C. R. H. (1991) J. Biol. Chem. 266, 9687-9696 [Abstract/Free Full Text]
  22. Schmidt, M. A., and Jann, K. (1983) Eur. J. Biochem. 131, 509-517 [Abstract]
  23. Bhattacharjee, A. K., Jennings, H. J., and Kenny, C. P. (1978) Biochemistry 17, 645-651 [Medline] [Order article via Infotrieve]
  24. Hamilton, C. M., Aldea, M., Washburn, B. K., Babitzke, P., and Kushner, S. R. (1989) J. Bacteriol. 171, 4617-4622 [Medline] [Order article via Infotrieve]
  25. Miller, J. R. (1972) Experiments in Molecular Genetics. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  26. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (1989) Current Protocols in Molecular Biology , John Wiley & Sons, Inc., New York
  27. Birnboim, H. C., and Doly, J. (1979) Nucleic Acids Res. 7, 1513-1523 [Abstract]
  28. Southern, E. M. (1975) J. Mol. Biol. 98, 503-517 [Medline] [Order article via Infotrieve]
  29. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  30. Hanahan, D. (1983) J. Mol. Biol. 166, 557-580 [Medline] [Order article via Infotrieve]
  31. Yanish-Perron, C., Viera, L., and Messing, J. (1985) Gene (Amst.) 33, 103-119 [CrossRef][Medline] [Order article via Infotrieve]
  32. Crowell, D. N., Anderson, M. S., and Raetz, C. R. H. (1986) J. Bacteriol. 168, 152-159 [Medline] [Order article via Infotrieve]
  33. Belunis, C. J., Mdluli, K. E., Raetz, C. R. H., and Nano, F. E. (1992) J. Biol. Chem. 267, 18702-18707 [Abstract/Free Full Text]
  34. Nishijima, M., and Raetz, C. R. H. (1979) J. Biol. Chem. 254, 7837-7844 [Medline] [Order article via Infotrieve]
  35. Galloway, S. M., and Raetz, C. R. H. (1990) J. Biol. Chem. 265, 6394-6402 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.